Pharvaris

The latest news about Pharvaris: headlines, AI summaries and the full story from every source.

• Pharvaris Director Sells $1.3 Million Worth of Shares Amid Strong Stock Performance Yahoo Finance · July 24, 2026, 11:21 UTC
• Pharvaris Publishes Review on Bradykinin B2 Receptor Antagonism for Angioedema GlobeNewsWire · July 22, 2026, 10:50 UTC